Jan 7, 2025 08:00AM
Dec 4, 2024 08:00AM
Oct 25, 2024 08:01AM
Oct 25, 2024 08:00AM
Sep 26, 2024 06:46AM
Sep 25, 2024 07:30AM
Sep 12, 2024 08:00AM Acasti to Present at the Life Sciences Investor Forum
Sep 5, 2024 10:35AM
Aug 9, 2024 08:00AM
Jun 27, 2024 04:05PM
Jun 21, 2024 08:00AM
May 28, 2024 04:05PM
Feb 12, 2024 08:00AM
Feb 1, 2024 08:00AM Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial
Dec 13, 2023 08:00AM
Nov 13, 2023 08:00AM
Oct 23, 2023 08:00AM
Oct 4, 2023 08:00AM
Sep 26, 2023 08:01AM
Sep 26, 2023 08:00AM
Sep 6, 2023 08:00AM Acasti to Participate in the H.C. Wainwright Global Investment Conference
Aug 11, 2023 07:00AM
Aug 9, 2023 04:05PM
Jul 10, 2023 09:00AM
Jul 7, 2023 08:00AM
Jul 7, 2023 08:00AM
Jul 5, 2023 09:00AM
Jul 5, 2023 09:00AM Acasti Announces Alignment with FDA on GTX-104 Pivotal Phase 3 Safety Trial Protocol and Confirms Planned Initiation of STRIVE-ON in aSAH Patients in Calendar Q4 2023
Jun 23, 2023 07:00AM
Jun 22, 2023 09:00AM
May 17, 2023 09:00AM
May 8, 2023 07:01AM
May 8, 2023 07:00AM
Apr 4, 2023 08:12AM
Apr 4, 2023 08:01AM Acasti to Proceed with Phase 3 Clinical Safety Study for GTX-104 Following FDA Feedback, and Upon Approval of the Full Study Protocol to be Submitted to the IND
Apr 4, 2023 08:00AM
Mar 30, 2023 08:33AM
Mar 30, 2023 08:30AM
Mar 13, 2023 08:00AM
Feb 28, 2023 01:00PM
Feb 14, 2023 07:00AM
Feb 7, 2023 09:00AM Acasti Pharma to Report Third Quarter 2023 Financial Results on Tuesday, February 14, 2023
Jan 25, 2023 09:01AM
Jan 25, 2023 09:00AM
Jan 24, 2023 04:15PM
Jan 17, 2023 08:45AM
Jan 13, 2023 09:00AM
Jan 5, 2023 09:00AM
Dec 28, 2022 08:03AM Acasti Pharma (ACST) Announces Preliminary Topline Results Met All Outcome Measures in the Pharmacokinetic Bridging Study for GTX-102
Dec 28, 2022 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All